Skip to content

Clinical trials

Muscular Atrophy, Spinal trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Muscular Atrophy, Spinal Country / region: Netherlands Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20151
20162
20171
20191
20211
20225
20233
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting5
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche6
Scholar Rock, Inc.4
Novartis Pharmaceuticals2
UMC Utrecht2
Biogen1
Biohaven Pharmaceuticals, Inc.1
NMD Pharma A/S1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Muscular Atrophy, Spinal17
Muscular Atrophy5
Spinal Muscular Atrophies of Childhood5
Neuromuscular Diseases4
Neuromuscular Manifestations4
Atrophy3
Bulbo-Spinal Atrophy, X-Linked2
Muscular Diseases2

Trials

Showing 76 to 17 of 17. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.